Number Needed to Treat (NNT) and Cost of Preventing an Event (COPE) Comparison Between the Association of Cobimetinib and Vemurafenib Among Other Treatment Options for Metastatic Melanoma With BRAF V600 Mutation
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2580
https://www.valueinhealthjournal.com/article/S1098-3015(17)32914-5/fulltext
Title :
Number Needed to Treat (NNT) and Cost of Preventing an Event (COPE) Comparison Between the Association of Cobimetinib and Vemurafenib Among Other Treatment Options for Metastatic Melanoma With BRAF V600 Mutation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32914-5&doi=10.1016/j.jval.2017.08.2580
First page :
A875
Section Title :
SELECTED HEALTH CARE TREATMENT STUDIES -MEDICAL DEVICE/DIAGNOSTICS
Open access? :
No
Section Order :
2378